SCHWAB CHARLES CORP (SCHW)
Form 8.3
Form 8.3
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)
Register of shareholders, changes and share capital status – changes in the company’s capital as a result of expiration and allocation of warrants
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 4:00 PM ET
Virtuix Provides Business Update Highlighting 3X Omni One Order Growth and Expanding Defense and Enterprise Opportunities
Stratasys Additive Manufacturing Solutions to Roll Out Across 20+ GM Manufacturing Facilities
Workiva to Host 2026 Analyst & Investor Day
Drift Invites Fans Back to Forks with an Exclusive Twilight x Drift Scent Collection
PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026